N
N07CA03 Flunarizine
[N07CA] Antivertigo preparations
[N07C] ANTIVERTIGO PREPARATIONS
[N07] OTHER NERVOUS SYSTEM DRUGS
[N] Nervous system
Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
---|---|---|---|---|---|
rat | LD50 | oral | 503mg/kg (503mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1408, 1975. | |
dog | LD50 | oral | > 2gm/kg (2000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
mouse | LD50 | intravenous | 27mg/kg (27mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
mouse | LD50 | intraperitoneal | 379mg/kg (379mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
mouse | LD50 | subcutaneous | > 2550mg/kg (2550mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
rat | LD50 | intraperitoneal | 305mg/kg (305mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
mouse | LD50 | oral | 285mg/kg (285mg/kg) | European Patent Application. Vol. #0187639, | |
rat | LD50 | subcutaneous | 1793mg/kg (1793mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
rat | LD50 | intravenous | 35mg/kg (35mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 16, Pg. 1735, 1982. | |
(E)-1-(Bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)piperazine | (E)-1-[Bis-(p-fluorophenyl)methyl]-4-cinnamylpiperazine | 1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine |
1-[BIS(4-FLUOROPHENYL)METHYL]-4-CINNAMYLPIPERAZINE | 1-[Bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]piperazine | 1-[Bis-(4-fluoro-phenyl)-methyl]-4-((E)-3-phenyl-allyl)-piperazine |
1-[Bis-(4-fluoro-phenyl)-methyl]-4-(3-phenyl-allyl)-piperazine | 1-[Bis-(4-fluoro-phenyl)-methyl]-4-(3-phenyl-allyl)-piperazine(Flunarizine) | 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine |
1-[bis(4-fluorophenyl)methyl]-4-[(E)-cinnamyl]piperazine | 1-[bis-(4-Fluorophenyl)methyl]-4-cinnamylpiperazine | 118378-EP2270011A1 |
118378-EP2275420A1 | 118378-EP2280008A2 | 118378-EP2298764A1 |
118378-EP2298765A1 | 4-((2E)-3-phenylprop-2-enyl)-1-[bis(4-fluorophenyl)methyl]piperazine | 40218-96-0 |
52468-60-7 | AB00053586-15 | AB00053586_16 |
AB00053586_17 | AC-1283 | ACM40218960 |
AKOS015960783 | API0002726 | AX8130500 |
BCBcMAP01_000120 | BDBM50017702 | BPBio1_000336 |
BRD-K12184470-300-01-8 | BRD-K29582677-001-02-7 | BRD-K29582677-300-05-6 |
BRD-K29582677-300-06-4 | BSPBio_000304 | BSPBio_001341 |
BSPBio_003096 | C26H26F2N2 | CAS-52468-60-7 |
CC-28469 | CCG-204617 | CHEBI:135652 |
CHEBI:92209 | CHEMBL30008 | D07971 |
DB04841 | DSSTox_CID_25616 | DSSTox_GSID_45616 |
DSSTox_RID_81005 | DTXSID6045616 | EINECS 254-842-0 |
EINECS 257-937-5 | Flunarazine | Flunarizin |
Flunarizina | Flunarizina [INN-Spanish] | Flunarizine (INN) |
Flunarizine [INN:BAN] | Flunarizine2HCl | Flunarizinum |
Flunarizinum [INN-Latin] | HMS1361D03 | HMS1791D03 |
HMS1989D03 | HMS2089H21 | IDI1_000043 |
IDI1_033811 | LS-110464 | Lopac0_000527 |
NCGC00018102-04 | NCGC00018102-05 | NCGC00018102-06 |
NCGC00018102-07 | NCGC00018102-08 | NCGC00018102-09 |
NCGC00018102-10 | NCGC00018102-12 | NCGC00024308-04 |
NCGC00024308-05 | NCGC00024308-06 | NCGC00024308-07 |
Narzine | Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)- | Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (E)- |
Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-, (E)- | Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]- | Prestwick2_000312 |
Prestwick3_000312 | Q416237 | R7PLA2DM0J |
SBI-0050510.P003 | SCHEMBL43440 | SCHEMBL43441 |
SMANXXCATUTDDT-QPJJXVBHSA-N | ST024768 | STL477617 |
Sibelium | Sibelium (TN) | Spectrum5_001570 |
Tox21_110825 | Tox21_110825_1 | UNII-R7PLA2DM0J |
ZINC19360739 | cid_6365505 | flunarizine |
DrugBank Name | Flunarizine |
DrugBank | DB04841 |
CAS Number | 27064-95-5, 30484-77-6, 40218-96-0, 52468-60-7, 5343-57-7 |
PubChem Compound | 941361 |
KEGG Drug | D01303 |
PubChem.Substance | 46507129 |
ChEBI | 135652 |
PharmGKB | PA164776636 |
ChemSpider | 819216 |
BindingDB | 50017702.0 |
TTD | DAP000142 |
Wikipedia | Flunarizine |
DPD | 11229|1252 |